Clinical Trial Update: Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

This document covers a Phase 4 clinical trial evaluating Nucleoid as adjuvant therapy after radiofrequency ablation in hepatocellular carcinoma, with the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nucleoid

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 4 | Status: UNKNOWN